Iliotibial Band SyndromeNCT06867159
Autogenic Inhibition Versus Reciprocal Inhibition Muscle Energy Techniques in Iliotibial Band Syndrome
A study testing Autogenic Inhibition (AI) MET (Post Facilitation Stretch) and Reciprocal Inhibition (RI) MET in people with Iliotibial Band Syndrome, run by Foundation University Islamabad at 1 site in Pakistan.
Trial summary
Comparison of effects of autogenic inhibition and reciprocal inhibition muscle energy techniques on iliotibial band syndrome Read more about this study
- Who is it for?
- Ages 19 to 45 years
- Conditions the study is for
- Iliotibial Band Syndrome
- What is being tested?
- Autogenic Inhibition (AI) MET (Post Facilitation Stretch) and Reciprocal Inhibition (RI) MET
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 sitePakistan
- Study dates
- 15 Jul 2024to 15 Jul 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 to 45 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Both male and female participants
- Age : 19-45years (8)
- Lateral knee pain (>3 months)
- Tenderness over lateral femoral condyle
- Positive Flexibility Tests
- Modified Ober's test (9)
Show all 10Show fewer
- Length assessment of Tensor Fasciae Latae and Iliotibial Band (10)
- Positive Pain Provocation Tests
- Renne's test
- Noble's Compression test (11) *(individuals with 3 positive tests out of above mentioned 4 tests will be included)
Who cannot join
- Recent lower limb or pelvic girdle surgery within the past 3 months
- Lower limb fractures or trauma within the past year.
- Multiple lower limb surgeries (>2)
- Presence of any structural or postural disorders (kyphosis or severe scoliosis)
- Neurological disorders
- Hip and knee Osteoarthritis
- Rheumatoid Arthritis
- Pregnancy
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Pakistan1 site, 1 recruiting
- Recruiting
Foundation University College of Physcial Therapy
Rawalpindi, Punjab Province, 46000
Furqan Yaqoob, OMPT,PHD*, 03465333101, furqan.yaqoob@fui.edu.pk
About this study
Official title: Comparison of Effects of Autogenic Inhibition and Reciprocal Inhibition Muscle Energy Techniques on Iliotibial Band Syndrome
Comparison of effects of autogenic inhibition and reciprocal inhibition muscle energy techniques on iliotibial band syndrome
Read the detailed description
A single-blinded randomized control trial will be conducted over a period of one year in Foundation University Islamabad. Forty participants will be assigned to two groups: Group A (AI) and Group B (RI), with 20 participants each. The AI technique will involve a maximal isometric contraction of the target muscle followed by a stretch, while the RI technique will involve a maximal isometric contraction of the antagonist muscle followed by a similar stretching protocol. Both groups will perform the exercises 3 times per week for 2 weeks. Pain, Hip range of motion (ROM) and lower extremity function will be assessed using Numeric Pain Rating Scale (NPRS), goniometer and Lower Extremity Functional Scale (LEFS) respectively.
The outcomes will be measured in terms of improvements in pain score (NPRS), hip range of motion (ROM), and overall lower extremity function.
- Conditions
- Iliotibial Band Syndrome
- Being tested
- Autogenic Inhibition (AI) MET (Post Facilitation Stretch), Reciprocal Inhibition (RI) MET
- Medical subject headings
- Iliotibial Band Syndrome
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Autogenic Inhibition (AI) MET (Post Facilitation Stretch)Procedure or surgery
Autogenic Inhibition (AI) MET (Post Facilitation Stretch)
- The shortened muscle (Tensor Fascia Latae) is placed in a mid-range position about halfway between a fully stretched and a fully relaxed state.
- The patient contracts the muscle isometrically, using a maximum degree of effort for 5-10 seconds while the effort is resisted completely.
- On release of the effort, a rapid stretch is made to a new barrier, without any 'bounce', and this is held for at least 10 seconds.
- The patient relaxes for approximately 20 seconds and the procedure is repeated between three and five times more.
Reciprocal Inhibition (RI) METProcedure or surgery
Reciprocal Inhibition (RI) MET
- The shortened muscle (Tensor Fascia Latae) is placed in a mid-range position about halfway between a fully stretched and a fully relaxed state.
- The patient contracts the antagonist muscles (hip adductors), using a maximum degree of effort for 5-10 seconds while the effort is resisted completely.
- On release of the effort, a rapid stretch to TFL is made to a new barrier, without any 'bounce', and this is held for at least 10 seconds.
- The patient relaxes for approximately 20 seconds and the procedure is repeated between three and five times more.
| Study group | Role | What they receive |
|---|---|---|
| Autogenic Inhibition (AI) MET Group | Experimental | Autogenic Inhibition (AI) MET (Post Facilitation Stretch)
1. The shortened muscle (Tensor Fascia Latae) is placed in a mid-range position about halfway between a fully stretched and a fully relaxed state.
2. The patient contracts the muscle isometrically, using a maximum degree of effort for 5-10 seconds while the effort is resisted completely.
3. On release of the effort, a rapid stretch is made to a new barrier, without any 'bounce', and this is held for at least 10 seconds.
4. The patient relaxes for approximately 20 seconds and the procedure is repeated between three and five times more. Receives: Procedure: Autogenic Inhibition (AI) MET (Post Facilitation Stretch) |
| Reciprocal Inhibition (RI) MET Group | Experimental | Reciprocal Inhibition (RI) MET
1. The shortened muscle (Tensor Fascia Latae) is placed in a mid-range position about halfway between a fully stretched and a fully relaxed state.
2. The patient contracts the antagonist muscles (hip adductors), using a maximum degree of effort for 5-10 seconds while the effort is resisted completely.
3. On release of the effort, a rapid stretch to TFL is made to a new barrier, without any 'bounce', and this is held for at least 10 seconds.
4. The patient relaxes for approximately 20 seconds and the procedure is repeated between three and five times more. Receives: Procedure: Reciprocal Inhibition (RI) MET |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pain severity
Pain will be assessed using Numeric Pain Rating Scale (NPRS),
Measured: 2 weeks
Range of motion
Hip range of motion (ROM) will be assessed using goniometer
Measured: 2 weeks
Functional status of lower limb
Lower extremity function will be assessed using Lower Extremity Functional Scale (LEFS)
Measured: 2 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Mar 2025
- Study start15 Jul 2024
- Primary completion15 Jun 2025 (estimated)
- Study completion15 Jul 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Iliotibial Band SyndromeStudies of the same condition, open and under way.
- More trials run by Foundation University IslamabadThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomized Controlled Trial
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Foundation University Islamabad
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06867159
- Sponsor's protocol ID
- FUI/CTR/2025/3
- Status last verified
- Mar 2025
- First submitted
- 4 Mar 2025
- Last updated
- 10 Mar 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 10 Mar 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Effects of Autogenic Inhibition and Reciprocal Inhibition Muscle Energy Techniques on Iliotibial Band Syndrome
- ClinicalTrials.gov ID
- NCT06867159
- Acronym / sponsor ID
- FUI/CTR/2025/3
- Conditions
- Iliotibial Band Syndrome
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- Foundation University IslamabadUniversity, hospital or other
- Study start
- 15 Jul 2024 (actual)
- Primary completion
- 15 Jun 2025 (estimated)
- Study completion
- 15 Jul 2025 (estimated)
- First posted
- 10 Mar 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Comparison of effects of autogenic inhibition and reciprocal inhibition muscle energy techniques on iliotibial band syndrome
Detailed description
A single-blinded randomized control trial will be conducted over a period of one year in Foundation University Islamabad. Forty participants will be assigned to two groups: Group A (AI) and Group B (RI), with 20 participants each. The AI technique will involve a maximal isometric contraction of the target muscle followed by a stretch, while the RI technique will involve a maximal isometric contraction of the antagonist muscle followed by a similar stretching protocol. Both groups will perform the exercises 3 times per week for 2 weeks. Pain, Hip range of motion (ROM) and lower extremity function will be assessed using Numeric Pain Rating Scale (NPRS), goniometer and Lower Extremity Functional Scale (LEFS) respectively.
The outcomes will be measured in terms of improvements in pain score (NPRS), hip range of motion (ROM), and overall lower extremity function.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Randomized Controlled Trial
| Arm | Type | Receives |
|---|---|---|
| Autogenic Inhibition (AI) MET Group | Experimental | Procedure: Autogenic Inhibition (AI) MET (Post Facilitation Stretch)Autogenic Inhibition (AI) MET (Post Facilitation Stretch) 1. The shortened muscle (Tensor Fascia Latae) is placed in a mid-range position about halfway between a fully stretched and a fully relaxed state. 2. The patient contracts the muscle isometrically, using a maximum degree of effort for 5-10 seconds while the effort is resisted completely. 3. On release of the effort, a rapid stretch is made to a new barrier, without any 'bounce', and this is held for at least 10 seconds. 4. The patient relaxes for approximately 20 seconds and the procedure is repeated between three and five times more. |
| Reciprocal Inhibition (RI) MET Group | Experimental | Procedure: Reciprocal Inhibition (RI) METReciprocal Inhibition (RI) MET 1. The shortened muscle (Tensor Fascia Latae) is placed in a mid-range position about halfway between a fully stretched and a fully relaxed state. 2. The patient contracts the antagonist muscles (hip adductors), using a maximum degree of effort for 5-10 seconds while the effort is resisted completely. 3. On release of the effort, a rapid stretch to TFL is made to a new barrier, without any 'bounce', and this is held for at least 10 seconds. 4. The patient relaxes for approximately 20 seconds and the procedure is repeated between three and five times more. |
Who may qualify
- Ages
- 19 to 45 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (10 listed)
- Both male and female participants
- Age : 19-45years (8)
- Lateral knee pain (>3 months)
- Tenderness over lateral femoral condyle
- Positive Flexibility Tests
Key exclusion criteria (8 listed)
- Recent lower limb or pelvic girdle surgery within the past 3 months
- Lower limb fractures or trauma within the past year.
- Multiple lower limb surgeries (>2)
- Presence of any structural or postural disorders (kyphosis or severe scoliosis)
- Neurological disorders
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Autogenic Inhibition (AI) MET (Post Facilitation Stretch)Autogenic Inhibition (AI) MET (Post Facilitation Stretch) 1. The shortened muscle (Tensor Fascia Latae) is placed in a mid-range position about halfway between a fully stretched and a fully relaxed state. 2. The patient contracts the muscle isometrically, using a maximum degree of effort for 5-10 seconds while the effort is resisted completely. 3. On release of the effort, a rapid stretch is made to a new barrier, without any 'bounce', and this is held for at least 10 seconds. 4. The patient relaxes for approximately 20 seconds and the procedure is repeated between three and five times more. | Procedure or surgery | Autogenic Inhibition (AI) MET Group |
| Reciprocal Inhibition (RI) METReciprocal Inhibition (RI) MET 1. The shortened muscle (Tensor Fascia Latae) is placed in a mid-range position about halfway between a fully stretched and a fully relaxed state. 2. The patient contracts the antagonist muscles (hip adductors), using a maximum degree of effort for 5-10 seconds while the effort is resisted completely. 3. On release of the effort, a rapid stretch to TFL is made to a new barrier, without any 'bounce', and this is held for at least 10 seconds. 4. The patient relaxes for approximately 20 seconds and the procedure is repeated between three and five times more. | Procedure or surgery | Reciprocal Inhibition (RI) MET Group |
Primary outcome
Pain severity
Time frame: 2 weeks
Pain will be assessed using Numeric Pain Rating Scale (NPRS),
Range of motion
Time frame: 2 weeks
Hip range of motion (ROM) will be assessed using goniometer
Functional status of lower limb
Time frame: 2 weeks
Lower extremity function will be assessed using Lower Extremity Functional Scale (LEFS)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Mar 2025.
Related trials for Iliotibial Band Syndrome
Not yet recruiting
Exercise Program for ITB Syndrome
Iliotibial Band Syndrome
Recruiting
Radial Extracorporeal Shockwave Therapy in Individuals With Iliotibial Band Syndrome
Iliotibial Band Syndrome
Active, not recruiting
Neuromuscular Inhibition Technique on Iliotibial Band Friction Syndrome
Iliotibial Band Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Autogenic Inhibition (AI) MET (Post Facilitation Stretch) and Reciprocal Inhibition (RI) MET in people with Iliotibial Band Syndrome, run by Foundation University Islamabad at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 10 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 10 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Rida Ishtiaq, MS-MSKPT* (03365530415, ridaishtiaq777@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pain severity (time frame: 2 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Mar 2025; AzTrials last refreshed its copy on 8 Nov 2026.